A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia

Exclusion Criteria

• •Pregnant or breastfeeding women.
• •Concurrent conditions and history of other protocol-specified diseases.
• •ANC \< 1.5 × 10\^9/L.
• •Platelet count \< 100 × 10\^9/L.
• •Severely impaired liver function.
• •Impaired renal function with estimated creatinine clearance less than 45 mL/min.
• •Anti-phospholipid antibodies positive or elevated anti-streptolysin antibodies.
• •Positive serology test results for hepatitis B surface antigen or core antibody, or hepatitis C virus antibody with detectable RNA at screening, consistent with active or chronic infection.
• •Known HIV infection or positivity on immunoassay.
• •History or presence of an abnormal ECG that, in the investigator's opinion, is clinically meaningful.
• •Known hypersensitivity or severe reaction to parsaclisib or its excipients.